Lung cancer is the most common type of cancer globally. According to WHO, lung cancer is expected to be more prominent in the underdeveloped world due to an increase in the use of tobacco products; tobacco is the primary cause of around 80% of all lung cancers. Global incidence of lung cancer was 1,608,055 in 2008 with the developing countries accounting for a major share (55%), 1,694,277 new cases were recorded in 2010 with 1,934,467, 2,213,561, and 2,530,820 as the predicted new cases for the years 2015, 2020, and 2025 respectively.
The lung cancer surgery market is expected to grow at a CAGR of 4.9% during the study period (2010-2015). Thoracotomy is the most widely used surgical procedure for lung cancer treatment accounting for about 74% of all surgical interventions. The market for lung cancer surgeries was valued at $36 billion in 2010 and is expected to grow to $45 billion by 2015. Rising incidence of non-small cell lung cancer globally is the major growth driver for the lung cancer surgery market. Europe accounted for the highest number (40%) of lung cancer surgeries performed in 2010.
Lung cancer surgery market is highly dynamic due to continuous R&D activity. Varying customer needs and special emphasis on minimally invasive surgical procedures have pushed the players such as Covidien Plc., AngioDynamics, and Ethicon Endosurgery to focus on new product development and launches. For instance, in January 2011, Covidien Plc. introduced the Endo GIA curved tip and black reloads with Tri-Stapler technology.
This analyst briefing focuses on the lung cancer surgery market over the period 2010-2015. The agenda for the briefing includes discussion on key high growth markets, marking the growth trend in the lung cancer surgery market. Furthermore, a briefing is conducted on the competitive scenario and geographic trends and opportunities in the macro- and micro-markets with respect to Europe, Americas, and ROW.
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
Note: An email containing the Login Details and Time of the Analyst Briefing will be sent to you soon after your registration.